# ALYFTREK
> **NDA218730** · New Drug Application · Sponsor: VERTEX PHARMS INC · Approved 2024-12-20
## Drug
- **FDA Application Number:** NDA218730
- **Application type:** New Drug Application
- **Brand name:** ALYFTREK
- **Generic name:** VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR
- **Active ingredients:** DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VERTEX PHARMS INC
- **Manufacturer:** Vertex Pharmaceuticals Incorporated
- **First approval:** 2024-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218730)
---
*AI Analytics · CC0 1.0*